Background: Recently, Tie2/TEK receptor tyrosine kinase (Tie2 or syn. angiopoietin-1 receptor) positive nucleus pulposus progenitor cells were detected in human, cattle, and mouse. These cells show remarkable multilineage differentiation capacity and direct correlation with intervertebral disc (IVD) degeneration and are therefore an interesting target for regenerative strategies.
. 4 The reduced ECM quality results in decreased IVD water retention, tissue flexibility, and mechanical loading capacity along the spine. [5] [6] [7] Expression of Tie2/TEK receptor tyrosine kinase (Tie2; also known as CD202) was identified as a marker of local NP progenitor cell population by Sakai et al 8 in human and murine NPs. These Tie2 + NP progenitor cells were characterized by assessment of the total isolated NPC population in methylcellulose semisolid medium, commonly used in colony forming assays (CFA) for endothelial and hematopoietic progenitor cells. [8] [9] [10] Two distinct colonies developed, that is, (1) fibroblastic colony forming units (CFU-F) and (2) spherical colony forming units (CFU-S), named based on their morphology ( Figure 2 ). High collagen type II and aggrecan protein expression was exclusively observed within CFU-S. Subsequently, NPCs surface marker was correlated to CFU-S forming capacity, and strong relationship was observed with Tie2 expression. NPCs were sorted based on Tie2 immunoreactivity and subsequently reassessed by CFA. This resulted in a high frequency of CFU-S in Tie2 + populations but not for Tie2 − populations. Notably, Tie2 + cells were identified as the precursor that further differentiated and started to express other surface markers, including GD2 (disialoganglioside 2) and CD24. 8 Moreover,
Tie2
+ cells showed the ability of cell renewal, which is lost with decrease of Tie2 expression. 8 Next, Tie2 + NPCs were assessed on marker expression of macrophage, endothelial cell or pericyte markers (ie, CD11c, CD14, CD31, CD34, CD45, CD144, CD146, and
Von Willebrand Factor) to exclude potential contamination, which resulted in no detected immunoreactivity. Also, direct immunostaining against Tie2 in IVD sections revealed distinct Tie2 expression in human and canine NPs ( Figure S1 , Supporting Information). To further investigate the progenitor cell characteristics of the Tie2 + NPCs, differentiation towards osteogenic, chondrogenic, and adipogenic lineages was successfully performed. Moreover, we observed that Tie2 positivity in the NPC population rapidly decreased with progression of IVD degeneration and aging in humans 8 ( Figure 3A ) and mice. 11 Li et al 12 later demonstrated that despite the relatively low Tie2 + NPCs numbers obtainable from degenerated IVD from patients with degenerative IVD disease, proliferation rate, lineage differentiation potency, and regenerative capacity was maintained. Interestingly, these Tie2 + NPCs had a superior differentiation capacity towards the chondrogenic lineage compared with bone marrow-derived mesenchymal stromal cells from the same patients. 12 Other studies demonstrated that transplanted Tie2 + NPCs could be differentiated towards Schwan-like cells resulting in improved functional recovery in murine sciatic peripheral nerves, again substantiating the progenitor-like nature. 13 Nevertheless, Tie2 + NPCs application remains limited due to the rapid reduction in ratio of Tie2 + NPCs with in vitro expansion ( Figure 3B ). 8, 14, 15 In particular,
Tekari et al 15 showed that Tie2 expression in bovine NPCs decreased from approximately 8% to less than 1% after 2.3 population doublings. Tie2 + preservation could, however, be augmented under hypoxic conditions, by supplementation of fibroblast growth factor 2 (FGF2) or synergistic FGF2 and hypoxic conditions ( Figure 3C ). 16 demonstrated a lack of Tie2 expression during the development of the fetal notochord up to 18 weeks postconception, indicating that Tie2 might not play a role during development. Nonetheless, after fetal IVD explantation, isolation, and culture we were able to detect Tie2 + NPCs from both human and canine fetal tissue ( Figure S1 ). Cumulatively, these data suggest a role for Tie2 + NPCs as an early-stage response to disruption in the environment to restore homeostasis of the IVD. Cell-based strategies for the treatment of chronic back and neck pain due to IVD degeneration have gained significant momentum, 17 but an optimal cell source remains elusive. Considering their clonal ability for multilineage differentiation potential comparable or even superior to mesenchymal stromal cells, 12 the Tie2 + NPCs can be considered a promising cell transplantation candidate. Tie2 + NPCs isolation not only provides an opportunity to study IVD homeostasis and the pathogenesis of IVD degeneration, but it also enables studying 12 Supplementation of 100 ng/mL FGF2, limited culture time and cell passaging can limit the loss of Tie2 expression ( Figure 3C ). 15 For murine specifically, it is highly recommended to expand primary isolated cells to induce Tie2 expression. Figure 3B ) and low Tie2 expression ( Figure 3A ), making it difficult to • ɑMEM (ThermoFisher, Cat. No. 12561056, https://www.
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thermofisher.com/order/catalog/product/12561056)
• Bovine serum albumin (BSA; Sigma-Aldrich, Cat. No. A9418-50G, http://www.sigmaaldrich.com/catalog/product/sigma/a9418?lang= ja&region=JP). Store at 4 C.
• Cell banker 1 (Zenoaq, CB011, http://www.zenoaq.jp/cellbanker/ ja/cellbanker1.html). Store at 2 to 8 C.
• Chlorhexidine digluconate (Hibiscrub, Cat. No. MRB319, http:// www.molnlycke.nl/antiseptica/whole-body-wash/hibiscrub/# confirm)
• Collagenase II (260 U/mg; Worthington, Cat. No. LS004176, http://www.worthington-biochem.com/cls/pl.html). Store at 2 C to 8 C, protected from moisture until reconstitution.
Caution: Highly toxic; prevent contact or inhalation by appropriate protection. The activity of the collagenase may change from batch-tobatch, as such check and adjust the mg employed as necessary to maintain the same levels of activity.
• , indicates successful FCM analysis; ☓, indicates lack of reactivity; ND, indicates that the antibodies reactivity has not been determined towards this species.
• EDTA•2Na (DOJINDO, Cat. No. 345-01865, http://www.siyaku.
com/uh/Shs.do?dspCode=W01T02N001)
• Ethanol (VWR, Cat. No. 20816.367, https://nl.vwr.com/store/ product/733114/vwrc20816).
Caution: Toxic and inflammable; Prevent contact or inhalation by appropriate protection.
• FACS buffer (PBS, 0.5% (v/v) BSA, 1 mM EDTA)
• FBS (ThermoFisher, Cat. No. 16000-044, https://www.thermo fisher.com/order/catalog/product/16000044)
• MethoCult H4230 methylcellulose-based medium without cyto- 
| Antibodies and FCM reagents
• Alexa Fluor 647 anti-human CD202b Antibody (Biolegend, Cat.
No. 334210, https://www.biolegend.com/en-gb/products/alexafluor-647-anti-human-cd202b-tie2-tek-antibody-5251)
• com/products/human-tie-2-apc-conjugated-antibody-83715_fab 3131a)
• Allophycocyanin-conjugated streptoavidin (BD Biosciences, Cat. • Surgical gloves (Gammex, http://www.ansell.com/en/Brands/ Gammex/Surgical%20Gloves/gammex-latex-chemo) 
| Nucleus pulposus cell isolation-Timing 5 to 10 hours
Critical: The protocol as described below is specified for moderately degenerated, adult human IVD tissue. Modifications of the protocol to address species or age-and disease-related alteration are specified or mentioned in "critical" sections. should be reduced to a minimum in these samples.
• Pause point: Place separated NP tissue in excessive serum-free medium (dependent on NP volume, minimally 10 mL) in a 15-or 50-mL conical tube on ice and store at 4 C for maximally 24 hours. 11. Wash the tissue twice by adding 25 mL of PBS and centrifuge the sample at 500g for 5 minutes at room temperature.
12. Discard the supernatant and add 25 mL (for NP tissue >2 mg) or 10 mL (for NP tissue <2 mg) collagenase P solution prepared in step 7 by decantation. (See Table 3 instead of 60 to 120 minutes.
14. Decant the cell suspension onto a 40-μm cell strainer on a 50-mL tube, removing undigested pieces of tissue by filtration.
Discard the strainer.
(a) For fetal and stillborn samples, skip this step to prevent further damage to the low cell numbers.
Wash the NPCs with αMEM supplemented with 10% (v/v) FBS
to inactivate the enzymes.
16. Centrifuge the cell suspension at 500g for 5 minutes at room temperature. Carefully discard the supernatant by decantation. Critical: Nonpassaged fetal-stillborn human and canine NPCs cannot be cryopreserved, since cell viability decreases considerably. Therefore, expand these NPCs one passage before cryopreserving them.
Critical: Cryopreservation has been shown to reduce the number of Tie2 + NPCs.
| Expansion of NPCs (optional)-Timing 7 days
Critical: Ideally, fresh, primary NPCs are used for Tie2 analysis and Limited NPCs are present Set the FSC-H and SSC-H gate over a larger region that captures 500 000 cells and narrow the gate later during the procedures to further specify the correct NPC population.
Release of antibody by harsh and repeated washing (in particular observed for fetal samples)
Limit the mechanical force generated during the washing step with FACS buffer, which might separate the antibody from its antigen, by gently adding the solutions via the inner wall of the tube in a slightly tilted position.
Reduce the number of washing repetitions during the staining procedures 52 Tie2 positive cells cannot be detected
The examined tissue is derived from aged, diseased, or degenerated tissue.
Do not digest tissue, but allow cells to be cultured inside their tissue sections prior to enzymatic digestion.
65
Cell sorting results in continuous clogging of the machinery flow path Aggregation of the NPC Limit the time of storing the cell suspension on ice prior to sorting Dilute the concentration of NPC suspension to limit the rate of aggregation Re-filter the cells using the cell strainer cap used in step 56 and 57 67 NPC population cannot be recognized
Cell suspension contains high numbers of dead cells, tissue debris, and non-NPC.
To remove erythrocytes and tissue and cell debris, lymphoprep (StemCell Technology, Cat. No. 07851) can be applied.
Limited NPCs are present Set the FSC-H and SSC-H gate over a larger region that captures 500 000 cells and narrow the gate later during the procedures to further specify the correct NPC population.
Release of antibody by harsh and repeated washing
Reduce the number of washing repetitions during the staining procedures
Critical: Vacuolated notochordal cells will adhere to the plate either as single cells or in clusters and will gradually lose their vacuolated phenotype over the period of 7 to 10 days. Critical: Assure that when applying a secondary antibody, the antibody is not reactive to the species of the tissue material, and is reactive to species from which the primary antibody was derived.
34. Leave on ice, kept from light, for 30 minutes. Table 3 for troubleshooting solutions.)
45. When all samples are analyzed, and data storage is completed, perform fluid management and cleaning as instructed by the manufacturer and progress to data analysis. Table 3 for troubleshooting solutions.) 65. Start the analysis using isotype control samples (Tube #1 from Table 1 ) to set up the gating for SSC-H and FSC-H, as well as PI positivity following step 39 to 40. Also establish the threshold for Tie2 positivity by setting the threshold of APC-intensity to the lowest intensity possible that allows for a population < 1.0%
on the right side of the threshold. (See Table 3 
TIMING
Step 1 to 20 Nucleus pulposus cell isolation: 5 to 10 hours
Step 21 to 27 Expansion of nucleus pulposus cells (optional):
days
Step 28 to 37 Antibody staining: 1 to 2 hours
Step 38 to 45 Data collection by FACS: 2 hours
Step 46 to 53 Data analysis and Tie2 detection: 2 hours
Step 54 to 69 Sorting of Tie2 + cells: 3 hours
Step 70 to 80 Colony-forming assay: 7 to 10 days
| RESULTS
Tie2 expression rapidly reduces in NP tissue obtained from patients above the age of 25, while NPs from patients older than 30 years of age demonstrate less than 10% Tie2 expression ( Figure 3A) . Similarly, Tie2 expression considerably decreases with IVD degeneration, demonstrating an average positivity of approximately 14% for grade III IVDs and less than 2.5% positivity for grade IV IVDs. 8 As the IVD tissue applied for research purposes is commonly explanted during surgery as part of a treatment of IVD degeneration or scoliosis, or as postmortem explantation, it is most likely to be prone to low Tie2 Murine samples also demonstrate an age-related Tie2 + ratio with a relatively low expression observed from 6 months of age. 
